Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV Endometrial Cancer
Conditions
- Endometrial Adenosquamous Carcinoma
- Endometrial Clear Cell Adenocarcinoma
- Endometrial Mixed Adenocarcinoma
- Endometrial Serous Adenocarcinoma
- Endometrial Squamous Cell Carcinoma
- Endometrial Undifferentiated Carcinoma
- Recurrent Uterine Corpus Carcinoma
- Stage IIIA Uterine Corpus Cancer
- Stage IIIC Uterine Corpus Cancer
- Stage IVA Uterine Corpus Cancer
- Stage IVB Uterine Corpus Cancer
Interventions
- DRUG: Cisplatin
- DRUG: Doxorubicin Hydrochloride
- BIOLOGICAL: Filgrastim
- DRUG: Paclitaxel
- BIOLOGICAL: Pegfilgrastim
Sponsor
Gynecologic Oncology Group
Collaborators